Latest AI and machine learning research in dementia for healthcare professionals.
OBJECTIVES: To systematically investigate the molecular associations between 6PPD-quinone (6PPD-Q), ...
Early detection of dementia is critical for timely intervention and disease management, yet it remai...
BACKGROUND AND OBJECTIVES: Outer nuclear layer (ONL) thinning has been identified in frontotemporal ...
BACKGROUND: Alzheimer disease (AD) is characterized by progressive cognitive decline, with olfactory...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading cause of dement...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that severely affects memory, c...
OBJECTIVES: Social determinants of health (SDOH) may improve Alzheimer's disease (AD) risk predictio...
Identifying individuals at risk of Alzheimer's disease (AD), particularly in the preclinical and ear...
Explainable Artificial Intelligence (XAI) is gaining popularity in early diagnosis and monitoring of...
We introduce a quantitative pipeline for region-level explanations of an Alzheimer's prediction mode...
OBJECTIVE: Reliable assessment of cerebral amyloid-β (Aβ) deposition is essential for the diagnosis ...
Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive impa...
INTRODUCTION: Seizure control is the primary therapeutic goal in pediatric epilepsy, yet its multidi...
BACKGROUND: Although large language models (LLMs) show potential for patient education, their accura...
BACKGROUND: Family caregivers experience conflicts in caring for people with Alzheimer's dementia (P...
Heparan sulfate (HS) proteoglycans are abundant, sulfation-patterned glycosaminoglycans on brain cel...
BackgroundThe systemic, metabolic, lifestyle factors have established associations with Alzheimer's ...
BACKGROUND: Everyday listening ability is essential for individual health and well-being. Age-relate...
The quick and accurate diagnosis of Alzheimer's disease (AD) and Frontotemporal Dementia (FTD) is a ...
UNLABELLED: Mild cognitive impairment (MCI) is a heterogeneous condition, with up to 40% of patients...
PURPOSE: Amyloid (A) deposition represents a specific pathological hallmark of Alzheimer's disease (...